v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows provided by operating activities:    
Net loss $ (16,324) $ (20,775)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 22,951 25,950
Stock-based compensation expense 5,576 7,514
Deferred taxes 5,316 (177)
Amortization of deferred financing costs and non-cash interest 410 413
Loss on held for sale and impairments 11,231 1,063
Bad debt expense 1,010 1,314
Other non-cash items (4,608) 4,641
Changes in operating assets and liabilities:    
Accounts receivable, net (4,485) (2,634)
Prepaid expenses and other current assets (3,087) (5,350)
Other non-current assets 93 1,278
Accounts payable (233) (247)
Accrued expenses and other (6,094) (848)
Deferred revenue 2,401 1,321
Other non-current liabilities (860) (763)
Net cash provided by operating activities 13,297 12,700
Cash flows used in investing activities:    
Purchases of property and equipment (402) (476)
Capitalization of software costs (4,432) (4,381)
Proceeds from disposition of fitness solutions, net of transaction costs, cash and restricted cash 1,228 0
Net cash used in investing activities (3,606) (4,857)
Cash flows used in financing activities:    
Payments on long-term debt (1,375) (1,375)
Exercise of stock options 1,072 609
Repurchase and retirement of common stock (12,068) (29,643)
Net cash used in financing activities (12,371) (30,409)
Effect of foreign currency exchange rate changes on cash (593) 50
Net decrease in cash, cash equivalents and restricted cash, including cash and restricted cash classified as held for sale (3,273) (22,516)
Cash, cash equivalents and restricted cash, including cash and restricted cash classified as held for sale:    
Beginning of period 96,179 95,824
End of period 92,906 73,308
Supplemental disclosures of cash flow information:    
Cash paid for interest 11,095 10,632
Cash paid for income taxes $ 1,654 $ 517